Category: Biopharmaceuticals
Global Biopharmaceuticals
-
The 2025-2030 World Outlook for Cancer Biologics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Cold Chain Logistics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Excipients
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals Manufacturing Consumables Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biologics Development and Manufacturing Testing
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals Contract Manufacturing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biologic Vasculitis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biologics Safety Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biopharma
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Stimulating Agents
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for PEGylated Proteins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Upstream Biopharmaceutical Fermentation Products
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)
... has released a research report titled “Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)” which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market ... Read More
-
Global Biosimilars Market Growth 2024-2030
... forecast to a readjusted size of US$ 18570 million by 2030 with a CAGR of 18.7% during review period. The research report highlights the growth potential of the global Biosimilars market. Biosimilars are expected to ... Read More
-
Global Erythropoietin Drugs Market Size study & Forecast, by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa), by Application (Cancer, Renal Disease, Neurology, Others), and Regional Analysis, 2023-2030
... USD 6.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% during the forecast period 2023-2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that ... Read More
-
Biosimilar Therapeutic Peptides Global Market Report 2024
... Disorders; Dermatology; Respiratory Disorders Covering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi SA Biosimilar Therapeutic Peptides Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Trastuzumab Biosimilars Global Market Report 2024
... Outlook Therapeutics lnc.; Merck & Co.; Amgen Inc.; BioXpress Therapeutics SA Trastuzumab Biosimilars Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Global Biosimilars - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 18.32% during the forecast period (2024-2029). The impact of COVID-19 on the biosimilars market may be significant, and it has imposed a great challenge on the pharmaceutical ... Read More
-
Biologics CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 12.78% during the forecast period (2024-2029). With an increasing number of companies within the pharmaceutical sector considering outsourcing services, the demand for services from contract manufacturing and ... Read More
-
2024 Global Other Biologics, Excluding Diagnostic, For Human Use Products Markets (2030 Outlook)
... for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) ... Read More
-
Bioprocess Analyzers Market (Product: Instruments and Consumables & Accessories: and Application: Antibiotics, Recombinant Proteins, Biosimilars, and Monoclonal Antibodies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Report TMR’s report on the global bioprocess analyzers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period ... Read More
-
Microcarriers Market - By Products (Consumables {Media, Microcarrier Beads}, Equipment {Bioreactor, Cell Counter}), Application (Biopharmaceutical Production, Regenerative Medicine), End-user (CROs, Research Institutes), Global Forecast, 2024 - 2032
... CAGR during 2024-2032, driven by Increasing adoption of microcarriers in cell culture processes, advancements in R&D activities, expanding applications beyond traditional cell culture processes, and rising demand for cell-based therapies and biologics. Urbanization leads to ... Read More
-
Recombinant Proteins Market Assessment, By Product [Cytokines and Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones, Others], By Host Cell [Mammalian Systems, Insect Cells, Yeast and Fungi, Bacterial Cells, Others], By Application [Academic Research Studies, Biopharmaceutical Production, Biotechnology Research, Diagnostics, Other Applications], By End-user [Pharmaceutical and Biotechnology Companies, Academics and Research Institutions, Clinical Research Organization, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Application [Academic Research Studies, Biopharmaceutical Production, Biotechnology Research, Diagnostics, Other Applications], By End-user [Pharmaceutical and Biotechnology Companies, Academics and Research Institutions, Clinical Research Organization, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F Global ... Read More
Research Assistance
